Aurinia Pharmaceuticals (AUPH) Times Interest Earned (2023 - 2026)

Aurinia Pharmaceuticals has reported Times Interest Earned for 4 years, with the latest figure at $40.93 in Q1 2026.

• For the quarter ending Q1 2026, Times Interest Earned rose 99.9% year-over-year to $40.93; the trailing twelve-month figure through Mar 2026 stood at $29.12 (up 342.27% YoY), and the FY2025 full-year result was $24.23, up 2599.47% from the prior year.
• Times Interest Earned for Q1 2026 stood at $40.93, up from $31.75 in the prior quarter.
• The five-year high for Times Interest Earned was $40.93 in Q1 2026, with the low at -$248.77 in Q2 2023.
• Historically, Times Interest Earned has averaged -$12.35 across 4 years, with a median of $4.23 in 2024.
• Annual changes were most pronounced in 2024 — Times Interest Earned jumped 93.57% — and 2025, when it surged 2279.86%.
• Aurinia Pharmaceuticals' Times Interest Earned stood at -$22.65 in 2023, then jumped by 93.57% to -$1.46 in 2024, then soared by 2279.86% to $31.75 in 2025, then increased by 28.93% to $40.93 in 2026.
• The last three Times Interest Earned figures came in at $40.93 (Q1 2026), $31.75 (Q4 2025), and $27.07 (Q3 2025), per Business Quant data.